Key result
Higher Osaka Prognostic Score is linked to ~13-fold higher in-hospital mortality after NSTEMI PCI.
Why the study?
Does a higher Osaka Prognostic Score predict increased in-hospital mortality in NSTEMI patients undergoing PCI?
Cohort (n=959)
Does a higher Osaka Prognostic Score predict increased in-hospital mortality in NSTEMI patients undergoing PCI?
Odds Ratio: 13.5 (95% CI 4.11–44.52)
Absolute Event Rate: 12.8% vs 3.6%
p-value: p=<0.001
The Osaka Prognostic Score, combining CRP, albumin, and total lymphocyte count, is a strong independent predictor of in-hospital mortality in NSTEMI patients undergoing PCI.
Objective Non-ST-segment elevation myocardial infarction (NSTEMI) remains a leading cause of morbidity and mortality worldwide. The Osaka Prognostic Score (OPS), a composite metric reflecting systemic inflammation and nutritional status through C-reactive protein (CRP), albumin, and total lymphocyte count (TLC), has been explored in various clinical settings. This study aimed to investigate the association between OPS and in-hospital mortality among NSTEMI patients undergoing percutaneous coronary intervention (PCI). Patients and Methods A retrospective cohort of 959 NSTEMI patients treated with PCI between September 2022 and November 2024 was analyzed. OPS was calculated by assigning one point each for CRP >10 mg/L, albumin <3.5 g/dL, and TLC <1,600/μL. Patients were categorized into four groups based on their OPS (0-3). The primary endpoint was in-hospital mortality, and multivariate logistic regression analysis was employed to identify independent predictors. Prognostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results Patients with higher OPS scores demonstrated significantly increased in-hospital mortality (OPS 2-3: 12.8% vs. OPS 0-1: 3.6%; p<0.001). Multivariate analysis identified OPS as an independent predictor of mortality (OR: 13.5, 95% CI: 4.11–44.52, p<0.001). ROC curve analysis yielded an area under the curve (AUC) of 0.898 for OPS, with 94% sensitivity and 74% specificity, outperforming other inflammatory and nutritional markers. Conclusions OPS is a robust independent predictor of in-hospital mortality in NSTEMI patients undergoing PCI. Its integration into routine clinical practice could enhance early risk stratification and optimize management strategies for high-risk patients. Further studies are warranted to validate these findings in diverse populations and assess its utility in predicting long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Tunca et al. (2025) conducted a cohort in Non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) (n=959). Higher Osaka Prognostic Score (OPS 2-3) vs. Lower Osaka Prognostic Score (OPS 0-1) was evaluated on in-hospital mortality (OR 13.5, 95% CI 4.11-44.52, p=<0.001). A higher Osaka Prognostic Score (2-3 vs 0-1) was associated with increased in-hospital mortality (12.8% vs 3.6%; OR 13.5, 95% CI 4.11-44.52, p<0.001) in NSTEMI patients undergoing PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: